GSTM1 and anemia (phenotype): These findings were not in agreement with those of Feng et al., who concluded that YYB significantly improved Hb levels and reduced anemia prevalence during the 1st–9th mo of intervention, but was not effective in the 10th–18th mo of intervention, and the greatest impacts were found at the 7th–9th mo of intervention [9].